Diagnostic value of ultrasonography in central lymph node metastasis of papillary thyroid carcinoma
CHEN Xinxin1 LIANG Yan1 CHEN Ling1 LIU Xiaolin1 LIU Guilian1 LIN Hongguo2
1.Department of Ultrasonic, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangdong Provincial Hospital of Chinese Medicine, Guangdong Province, Guangzhou 510120, China;
2.Department of Thyroid Surgery, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangdong Provincial Hospital of Chinese Medicine, Guangdong Province, Guangzhou 510120, China
Abstract：Objective To explore the diagnostic value of ultrasonography in central lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC). Methods A retrospective analysis was performed on 113 patients with PTC confirmed by pathology who underwent thyroid cancer surgery in Guangdong Provincial Hospital of Chinese Medicine from November 2018 to July 2019. The maximum diameter, shape, edge, aspect ratio, internal echo, calcification, posterior echo, capsule invasion, blood flow signal, and other ultrasonic characteristics were observed; the diagnostic value of ultrasound in CLNM of PTC patients was analyzed. Results Among 113 patients with PTC, preoperative ultrasound showed CLNM in 37 cases, and pathological results showed CLNM in 52 cases. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of preoperative ultrasonic diagnosis of CLNM in PTC patients were 61.5%, 91.8%, 77.9%, 86.5%, and 73.7%, respectively. There were statistically significant differences in maximum nodule diameter, microcalcification, and capsule invasion in patients with or without CLNM (P＜0.05). Conclusion For patients with maximum diameter of PTC nodule ≥1.5 cm, capsule invasion, and microcalcification, cervical CLNM is prone to occur, and preoperative examination and evaluation of cervical lymph nodes should be paid attention to and standardized.
陈欣欣1 梁雁1 陈铃1 刘晓琳1 刘桂连1 林鸿国2. 超声在甲状腺乳头状癌中央区淋巴结转移中的诊断价值[J]. 中国医药导报, 2023, 20(7): 157-160.
CHEN Xinxin1 LIANG Yan1 CHEN Ling1 LIU Xiaolin1 LIU Guilian1 LIN Hongguo2. Diagnostic value of ultrasonography in central lymph node metastasis of papillary thyroid carcinoma. 中国医药导报, 2023, 20(7): 157-160.
[1] Miranda-Filho A，Lortet-Tieulent J，Bray F，et al. Thyroid cancer incidence trends by histology in 25 countries：a population-based study [J]. Lancet Diabetes Endocrinol，2021，9（4）：225-234.
[2] Mao J，Zhang Q，Zhang H，et al. Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma：A Systematic Review and Meta-Analysis [J]. Front Endocrinol（Lausanne），2020，11：265.
[3] Yuan J，Li J，Chen X，et al. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma [J]. Bull Cancer，2017， 104（6）：516-523.
[4] 李云雪，王刚，孙备，等.甲状腺乳头状癌颈部淋巴结转移的处理态度和诊疗现状[J].实用肿瘤学杂志，2020，34（6）：530-534.
[5] Hu D，Zhou J，He W，et al. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma [J]. World J Surg Oncol，2018，16（1）：30.
[6] Kim D，Kwon HK，Shin SC，et al. Right posterior paratracheal lymph nodes metastasis is one of the predictive factorsin right-sided papillary thyroid carcinoma [J]. Surgery，2019， 166（6）：1154-1159.
[7] 庄玲玲.声像图所示甲状腺恶性结节钙化特点与组织病理类型分析[J].中国医学影像技术，2019，35（8）：1271- 1273.
[8] Song L，Zhou J，Chen W，et al. Lymph node metastasis between the sternocleidomastoid and sternohyoid muscle in papillary thyroid carcinoma patients：A prospective study at multiple centers [J]. Asian J Surg，2021，44（8）：1043-1049.
[9] 苏彪，史宜鑫，陈林，等.常规超声特征预测甲状腺乳头状癌颈部淋巴结转移的价值[J].中国超声医学杂志，2022， 38（6）：622-625.
[10] 孙芳，石岩，杨智，等.剪切波联合二维超声对甲状腺乳头状癌中央区淋巴结转移的预测价值[J].实用医学杂志，2021，37（14）：1866-1871.
[11] Zhao H，Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer：Diagnosis of central and lateral compartment nodal metastases [J]. Eur J Radiol，2019，112：14-21.
[12] Botha M，Kisansa M，Greeff W. American College of Radiology Thyroid Imaging Reporting and Data System standardises reporting of thyroid ultrasounds [J]. SA J Radiol，2020，24（1）：1804.
[13] Kong QF，Lv B，Wang B，et al. Association of von Willebrand factor （vWF） expression with lymph node metastasis and hemodynamics in papillary thyroid carcinoma [J]. Eur Rev Med Pharmacol Sci，2020，24（5）：2564-2571.
[14] Abboud B，Smayra T，Jabbour H，et al. Correlations of neck ultrasound and pathology in cervical lymph node of papillary thyroid carcinoma [J]. Acta Chirurgica Belgica，2020， 120（4）：238-244.
[15] Kim BY，Choi N，Kim SW，et al. Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma [J]. Eur Arch Otorhinolaryngol，2020，277（2）：569-576．
[16] Zhao W，You L，Hou X，et al. The effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy：a systematic review and meta analysis：pCND for the locoregional recurrence of papillary thyroid cancer [J]. Ann Surg Oncol，2017，24（8）：2189-2198．
[17] Wang QC，Cheng W，Wen X，et al. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma [J]. Asian Pac J Cancer Prev，2014，15（2）：855-860.
[18] 许晓华，苏琳，贾丹，等.单灶甲状腺乳头状癌淋巴结转移超声特征分析[J].肿瘤预防与治疗，2020，33（11）：841- 847.
[19] Liu Y，Li S，Yan C，et al. Value of dual-phase，contrast-enhanced CT combined with ultrasound for the diagnosis of metastasis to central lymph nodes in patients with papillary thyroid cancer [J]. Clin Imaging，2021，75（1）：5-11.
[20] 栾艳艳，郑云，王玉玲，等.SWE定量技术评价cN0期甲状腺乳头状癌中央区淋巴结的价值[J].医学影像学杂志，2022，32（7）：1135-1138.
[21] Jiang J，Shang X，Zhang H，et al. Correlation between maximum intensity and microvessel density for differentiation of malignant from benign thyroid nodules on contrast-enhanced sonography [J]. J Ultrasound Med，2014，33（7）：1257- 1263 .
[22] Erickson LA，Chen B. Papillary Thyroid Carcinoma BRAF Immunopositivity [J]. Mayo Clinic Proceedings，2021，96（1）：267-268.
[23] 王剑锋，张越，朱红霞.甲状腺乳头状癌患者术前超声造影与临床病理特征及预后的相关性[J].临床和实验医学杂志，2021，20（4）：417-420.
[24] Feng JW，Pan H，Wang L，et al. Total tumor diameter：the neglected value in papillary thyroid microcarcinoma [J]. J Endocrinol Invest，2020，43（5）：601-613．
[25] 张洁，冯艳红，何秀丽，等.常规超声特征及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J].临床耳鼻咽喉头颈外科杂志，2022，36（3）：184-188.
[26] 孙可敏，何秀丽，郭玲玲.甲状腺微小乳头状癌临床及超声特征与中央区淋巴结转移的危险因素[J].临床耳鼻咽喉头颈外科杂志，2021，35（3）：260-263.
[27] 牟德武，陈茂山，樊莉，等.单侧甲状腺乳头状癌对侧中央区淋巴结转移的相关危险因素分析[J].中国当代医药，2021，28（14）：95-98，102.
[28] 闻鉴非，张浩.单灶cT1N0期甲状腺乳头状癌中央区淋巴结转移因素分析[J].中国临床研究，2022，35（11）：1540- 1543.
京公网安备 11010502046598号